Boston Scientific is dedicated to transforming lives through innovative medical solutions that improve the health of patients around the world.
The company's Peripheral Interventions Business Unit delivers meaningful innovation in minimally invasive therapies for arterial disease, venous disease and cancers, encompassing Peripheral Artery Disease, Deep Vein Thrombosis, Critical Limb Ischemia, Superficial Venous Disease, Pulmonary Embolism and Liver and Kidney Cancer.